CTRI/2018/04/012963已完成未知
Breast cancer classification according to immunohistochemistry markers and its relationship with clinicopathological features, treatment outcome and survival analysis.
Government funded Institution0 个研究点目标入组 286 人开始时间: 待定最近更新:
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 286
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
入选标准
- •Unilateral, biopsy proven invasive ductal carcinoma(IDC) breast with baseline normal hematological, renal and hepatic profile and baseline normal cardiac and pulmonary function status. Any T, any N, M0 stage.
排除标准
- •Any evidence of distant metastasis at presentation, pregnant or lactating patients, previous history of any breast malignancy, presence of serious comorbidities or deranged hematological or biochemical parameters.
研究者
相似试验
尚未招募
Unknown
Studying patients presenting to GMCH with Breast cancer and classifying them into molecular subgroupsCTRI/2023/11/060202Government Medical College and Hospital, Sector 32 Chandigarh
招募中
不适用
Tumor differentiation in breast carcinomas with a novel physical methodC50Malignant neoplasm of breastDRKS00012767Department für Frauengesundheit150
招募中
不适用
Tumor response assessment in breast cancer patients receiving neoadjuvant systemic therapy using optical mammography: the Softscan Studymammacarcinoma10006291breast cancerNL-OMON36040eids Universitair Medisch Centrum42
招募中
不适用
Immunohistochemical analysis of malignancy grade in patients with intrahepatic cholangiocarcinoma.Intrahepatic cholangiocarcinomaJPRN-UMIN000009210Department of Gastroenterological Surgery, Yokohama City University Graduated school of Medicine100
招募中
不适用
Hereditary breast cancer and the clinical significance of variants in the BRCA1 and BRCA2 genes.hereditary breast cancermamma carcinoma1008362410006291NL-OMON37491eids Universitair Medisch Centrum270